Pretomanid is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Mylan Specialty L.p.. The primary component is Pretomanid.
| Product ID | 49502-476_5dd0a13a-c8f0-413f-8306-92c479195e0f |
| NDC | 49502-476 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Pretomanid |
| Generic Name | Pretomanid |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-11-07 |
| Marketing Category | NDA / NDA |
| Application Number | NDA212862 |
| Labeler Name | Mylan Specialty L.P. |
| Substance Name | PRETOMANID |
| Active Ingredient Strength | 200 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2019-11-07 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA212862 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-11-15 |
| Marketing End Date | 2019-10-18 |
| Marketing Category | NDA |
| Application Number | NDA212862 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-08-14 |
| Marketing End Date | 2019-10-18 |
| Marketing Category | NDA |
| Application Number | NDA212862 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-11-15 |
| Marketing End Date | 2019-10-18 |
| Marketing Category | NDA |
| Application Number | NDA212862 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-11-07 |
| Ingredient | Strength |
|---|---|
| PRETOMANID | 200 mg/1 |